ASIC3
Basic information
Region (hg38): 7:151048292-151052756
Previous symbols: [ "ACCN3" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ASIC3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 54 | 62 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 56 | 7 | 2 |
Variants in ASIC3
This is a list of pathogenic ClinVar variants found in the ASIC3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-151048910-G-A | not specified | Uncertain significance (Aug 21, 2023) | ||
7-151048920-G-A | not specified | Uncertain significance (Nov 15, 2021) | ||
7-151048929-C-T | not specified | Uncertain significance (Mar 12, 2024) | ||
7-151048938-G-A | not specified | Uncertain significance (Sep 06, 2022) | ||
7-151048940-G-A | not specified | Uncertain significance (May 17, 2023) | ||
7-151048958-T-C | not specified | Uncertain significance (Apr 18, 2023) | ||
7-151048959-C-T | not specified | Uncertain significance (Jan 23, 2023) | ||
7-151048979-G-A | not specified | Uncertain significance (Mar 12, 2024) | ||
7-151049007-G-A | not specified | Uncertain significance (Aug 08, 2022) | ||
7-151049010-G-C | not specified | Uncertain significance (Oct 10, 2023) | ||
7-151049017-G-A | not specified | Uncertain significance (Apr 07, 2022) | ||
7-151049022-C-T | not specified | Uncertain significance (Jul 12, 2022) | ||
7-151049078-C-T | not specified | Uncertain significance (Dec 26, 2023) | ||
7-151049120-C-T | Uncertain significance (May 20, 2022) | |||
7-151049121-G-A | not specified | Uncertain significance (Jan 26, 2022) | ||
7-151049145-C-T | not specified | Uncertain significance (Jun 23, 2023) | ||
7-151049195-C-T | not specified | Uncertain significance (Jul 09, 2021) | ||
7-151049243-G-A | not specified | Uncertain significance (Aug 08, 2022) | ||
7-151049255-G-A | not specified | Uncertain significance (Feb 27, 2024) | ||
7-151049265-G-A | Benign (Apr 07, 2018) | |||
7-151049265-G-T | not specified | Uncertain significance (May 14, 2024) | ||
7-151049273-G-A | not specified | Uncertain significance (Oct 26, 2022) | ||
7-151049289-C-T | not specified | Uncertain significance (Apr 17, 2024) | ||
7-151049294-G-A | not specified | Uncertain significance (Feb 28, 2023) | ||
7-151049332-CTA-C | Uncertain significance (May 20, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ASIC3 | protein_coding | protein_coding | ENST00000297512 | 11 | 4465 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.41e-7 | 0.986 | 125345 | 0 | 400 | 125745 | 0.00159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.631 | 387 | 354 | 1.09 | 0.0000221 | 3524 |
Missense in Polyphen | 148 | 138.67 | 1.0673 | 1382 | ||
Synonymous | -1.07 | 165 | 148 | 1.11 | 0.00000982 | 1144 |
Loss of Function | 2.26 | 15 | 27.9 | 0.537 | 0.00000167 | 265 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00163 | 0.00163 |
Ashkenazi Jewish | 0.000204 | 0.000198 |
East Asian | 0.00142 | 0.00141 |
Finnish | 0.000786 | 0.000786 |
European (Non-Finnish) | 0.00243 | 0.00243 |
Middle Eastern | 0.00142 | 0.00141 |
South Asian | 0.00121 | 0.00121 |
Other | 0.000815 | 0.000815 |
dbNSFP
Source:
- Function
- FUNCTION: Cation channel with high affinity for sodium, which is gated by extracellular protons and inhibited by the diuretic amiloride. Generates a biphasic current with a fast inactivating and a slow sustained phase. In sensory neurons is proposed to mediate the pain induced by acidosis that occurs in ischemic, damaged or inflamed tissue. May be involved in hyperalgesia. May play a role in mechanoreception. Heteromeric channel assembly seems to modulate channel properties. {ECO:0000269|PubMed:9744806, ECO:0000269|PubMed:9886053}.;
- Pathway
- Inflammatory mediator regulation of TRP channels - Homo sapiens (human);Stimuli-sensing channels;Ion channel transport;Transport of small molecules
(Consensus)
Intolerance Scores
- loftool
- rvis_EVS
- 0.25
- rvis_percentile_EVS
- 69.62
Haploinsufficiency Scores
- pHI
- 0.0366
- hipred
- N
- hipred_score
- 0.299
- ghis
- 0.517
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Asic3
- Phenotype
- homeostasis/metabolism phenotype; cellular phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- signal transduction;sensory perception;response to heat;response to acidic pH;ion transmembrane transport;sodium ion transmembrane transport;enterobactin transport;sensory perception of sour taste;detection of temperature stimulus involved in sensory perception of pain;detection of mechanical stimulus involved in sensory perception of pain;detection of chemical stimulus involved in sensory perception of pain
- Cellular component
- plasma membrane;integral component of plasma membrane;perinuclear region of cytoplasm
- Molecular function
- cation channel activity;sodium channel activity;enterobactin transmembrane transporter activity;acid-sensing ion channel activity